Tag Archives: Lawyers Collective

Lawyers Collective Response to Testimony of Mr. Roy F Waldron, Pfizer Inc.

Source: Lawyers Collective Recently, several multinational pharmaceutical companies along with the US Chamber of Commerce have been instrumental in mounting pressure on India to decry the alleged state of Intellectual Property (IP) regime in India. On June 27, 2013 a … Continue reading

Posted in Compulsory Licensing, Generics, IP Rights, Novartis Case, Patent examination system, Patents, Pricing, Right to Health, Sec 3 (d) | Tagged , , | Leave a comment

Indian Court Limits Frivolous Drug Patenting, Clearing Path to Affordable Medicines

Source: Open Society Foundations Azadeh Momenghalibaf /January 3, 2013 Should pharmaceutical patents—which result in monopolistic pricing of medicines—apply to any new drug, regardless of how it was made and whether it offers anything new? This question was answered recently in … Continue reading

Posted in Evergreening, Hepatitis C | Tagged , , , | Leave a comment